Publicaciones (669) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. #Pathart and cytopathology: Beauty must be shared

    Cytopathology, Vol. 35, Núm. 3, pp. 432-437

  2. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

    ESMO Open, Vol. 9, Núm. 2

  3. 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential

    Supportive Care in Cancer, Vol. 32, Núm. 1

  4. 3-T MR-guided focused ultrasound thalamotomy for tremor in patients with a cardiac pacemaker: case series and review of the literature

    Neurosurgical Focus , Vol. 57, Núm. 3

  5. A Bioreactor for Celullarised Membrane Culture and Delivery under Sterile Conditions

    Bioengineering, Vol. 11, Núm. 8

  6. A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections

    Cells, Vol. 13, Núm. 11

  7. A New Suppression Index Calculation Using the Visually Enhanced Vestibulo-Ocular Reflex and Vestibulo-Ocular Reflex Suppression Paradigms in the Video Head Impulse Test

    Audiology Research, Vol. 14, Núm. 4, pp. 747-759

  8. A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis

    Cancers, Vol. 16, Núm. 9

  9. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey

    European Journal of Surgical Oncology, Vol. 50, Núm. 10

  10. A new framework for the diagnosis, staging and management of obesity in adults

    Nature Medicine

  11. A new score for airway assessment using clinical and ultrasound parameters

    Frontiers in Medicine, Vol. 11

  12. A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

    Future oncology (London, England), Vol. 20, Núm. 13, pp. 799-809

  13. A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

    Future Oncology, Vol. 20, Núm. 13, pp. 799-809

  14. A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-associated hepatitis

    Hepatology Communications, Vol. 8, Núm. 8

  15. A retrospective study of deep learning generalization across two centers and multiple models of X-ray devices using COVID-19 chest-X rays

    Scientific Reports, Vol. 14, Núm. 1

  16. A road map for the treatment of pediatric diffuse midline glioma

    Cancer Cell

  17. APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases

    Frontiers in Molecular Neuroscience, Vol. 17

  18. ASL lexicon and reporting recommendations: A consensus report from the ISMRM Open Science Initiative for Perfusion Imaging (OSIPI)

    Magnetic Resonance in Medicine, Vol. 91, Núm. 5, pp. 1743-1760

  19. ASO Author Reflections: Confronting Challenges with Creativity: Innovating Minimally Invasive Pancreatic Surgery

    Annals of Surgical Oncology, Vol. 31, Núm. 7, pp. 4698-4699

  20. ASO Author Reflections: The Integration of Precision Anatomy Concepts into Minimally Invasive Liver Surgery—A New Way to Approach Routine Clinical Practice Complex Situations

    Annals of Surgical Oncology, Vol. 31, Núm. 6, pp. 4050-4051